Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
This study is ongoing, but not recruiting participants.
Medical Research Council
Information provided by:
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: December 18, 2013
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|
Kluin-Nelemans HC, Buck G, le Cessie S, Richards S, Beverloo HB, Falkenburg JH, Littlewood T, Muus P, Bareford D, van der Lelie H, Green AR, Roozendaal KJ, Milne AE, Chapman CS, Shepherd P; MRC and HOVON groups.. Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups. Blood. 2004 Jun 15;103(12):4408-15.